# Dongxiao Biotechnology’s first-half profit falls as Lysine prices and export curbs pressure margins

> Dongxiao Biotechnology reported first-half 2026 revenue down 2.03% and net profit down 51.76%. The company blamed lower lysine prices, export restrictions and weak pig-sector demand. Gross margin fell to 9.65%, and anti-dumping duties in the EU, US and Brazil were cited as pressure.

- Date: 2026-08-31 · published 2026-08-31T12:00:00.000Z
- Category: trade · region China · magnitude low
- Page: https://feedsoft.ai/events/18236-dongxiao-biotechnology-s-first-half-profit-falls-as-lysine-prices-and-export
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

Weak Chinese lysine pricing and producer margin pressure point to continued cheap supply, though trade barriers limit export volumes. Feed buyers outside China may see stable to lower lysine costs.

## Read by commodity

- LYSINE: bearish ▼

## Sources

- agrospectrumasia.com: https://www.agrospectrumasia.com/news/27/4571/dongxiao-biotechnologys-first-half-profit-falls-as-lysine-prices-and-export-curbs-pressure-margins.html

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.